周二盘后，脑再生科技（RGC）股价大涨7.19%，延续了盘中的强劲涨势。该股今日盘中已经上涨41.94%并触发熔断机制，引发市场广泛关注。
脑再生科技股价的持续上涨主要受益于脑机接口概念的持续发酵。近期，脑机接口概念股在美国、香港和中国A股市场集体爆发。马斯克旗下的Neuralink公司估值已达90亿美元，并已在第三位受试者体内植入脑机芯片，计划在2025年再植入20-30例。业内预计，未来3至5年脑机接口医疗产品有望迎来爆发期。这一技术发展前景激发了投资者对脑科学相关企业的热情。
值得注意的是，作为在美上市的中概股，脑再生科技今年以来表现亮眼。截至6月18日，该公司股价已累计上涨超过599倍，市值高达385亿美元（约合2772亿人民币）。脑再生科技专注于中医药治疗神经认知障碍和退化，特别是注意力缺陷与多动障碍（ADHD）和自闭症谱系障碍（ASD）。然而，投资者也应当注意到，如此巨大的涨幅伴随着较高的波动性和风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.